How Dynamisch’s Military-Grade Color Vision Testing Software Revolutionizes Patient Care

Client Challenge

The client is a leading innovator in specular microscopy, a field pushing the boundaries of medical technology. This forward-thinking company envisioned a drastic change. Traditionally, color vision deficiency (CVD) diagnosis relied on paper-based tests and cumbersome books.

They sought our expertise to transform this outdated method into a modern, scalable solution that eliminates: 

Paper Reliance -

The existing system, dependent on physical materials, lacked flexibility and scalability.

Limited Reach -

Paper-based tests restrict access, hindering efficient CVD diagnosis in various settings.

Data Inaccessibility -

Paper records make data collection and analysis cumbersome, hindering research and development efforts.

Lack of HIPAA Compliance -

Patient data security is paramount. The new platform needed to meet strict HIPAA regulations.

Solutions Offered

We crafted a cutting-edge suite of tools to revolutionize CVD diagnosis that offers: 

Multi-Platform Accessibility

Seamless B2B mobile apps, desktop applications, and a user-friendly website offered ophthalmologists convenient access to the testing platform. 

Dynamic Test Management

A robust backend system empowered ophthalmologists to adjust test questions and images on-the-fly. This flexibility ensured adaptability to evolving testing protocols and personalized patient assessments. 

Real-Time Data Synchronization

Changes made to the backend instantly reflected across all mobile and desktop apps, guaranteeing consistency and efficiency. 

HIPAA-Compliant Development

Data confidentiality was a top priority. We built the platform using secure development practices and open-source languages, ensuring patient information remained protected. 

Flexible Billing System

The platform accommodated diverse business models, supporting both pay-per-use and revenue-sharing options with integrated MIS (Management Information System) reports for transparent tracking. 

The Results Speak For Themselves

Dynamisch delivered a state-of-the-art platform boasting several key features:

  • Open-Source Efficiency – Utilizing readily available languages kept development costs in check while maintaining robust functionality. 
  • Secure Communication –Restful APIs with OAuth 2.0 ensured secure data exchange between mobile apps, desktop applications, and the website. 
  • HIPAA-Compliant Platform – The platform adhered to the latest HIPAA regulations, guaranteeing patient data protection. 
  • Gold Standard Integration – The mobile and desktop apps incorporated the industry-recognized Farnsworth D15 arrangement test, essential for medical insurance purposes. 
  • Comprehensive and Reliable – The platform was rigorously validated by the Naval Aerospace Medical Institute, ensuring accurate assessments of CVD type (Protan, Deutan, Tritan) and severity (mild, moderate, severe). It offered self-scored reports for an efficient diagnosis process. 

The Impact

This project transcended mere technological development. It redefined CVD diagnosis, offering tangible benefits:

  • Enhanced Accessibility – Ophthalmologists gained convenient access to a reliable CVD testing platform, improving patient care delivery.
  • Streamlined Workflow – The platform facilitated efficient test administration, scoring and reporting, saving valuable time for medical professionals.
  • Improved Data Collection – Secure data collection and analysis empowered researchers to gain deeper insights into CVD, paving the way for advancements in diagnosis and treatment.
  • Revolutionized Industry Standard – The platform presented a new standard for CVD diagnosis, contributing to the overall improvement of patient care within the ophthalmology field.